Vor Biopharma Inc. - Common Stock, par value $0.0001 per share (VOR)

CUSIP: 929033207

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
+609,928
SEC-reported price per share
$18.41
Number of holders
7
Value change
+$11,267,259
Number of buys
6
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
65,014,347

Security key

929033207

Report period

Q2 2026

Institutions

7

Top holders

7

Ownership snapshot

Top reported holders of VOR - Vor Biopharma Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13F 13D/G 3/4/5 Lead comparable stake: 20% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 20%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 20%
Reprogrammed Interchange LLC 18%
TCG Crossover GP II, LLC 10%
ForGrowth III PA B.V. 10%
Venrock Healthcare Capital Partne... 9.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G
Company
20%
from 13D/G
$96,425,164
5,404,998 shares
31 Mar 2026
Reprogrammed Interchange LLC
13D/G 3/4/5
10%+ Owner
18%
$48,045,191
1,204,442 shares
$0 15 Oct 2025
TCG Crossover GP II, LLC
3/4/5 13D/G
10%+ Owner · Chen Yu
10%
from 13D/G
$37,101,930
2,836,539 shares
30 Mar 2026
ForGrowth III PA B.V.
13D/G
10%
$81,492,203
10,237,714 shares
+$25,772,203 18 Dec 2025
Venrock Healthcare Capital Partners III, L.P.
13D/G
9.9%
$91,763,980
5,083,877 shares
+$51,763,826 31 Mar 2026
Verve Capital Ltd
13D/G
Verve Capital Limited
9.3%
$90,236,860
4,999,272 shares
+$12,667,634 31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
7
Shares
687,020
Rows available
7
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
80
Q2 2026 holders
7
Holder diff
-73
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .